2-(.alpha.-(P-Chlorophenoxy)-isobutyryl)-aminoethanesulfonic acid and the salts thereof, which possess valuable pharmacological and therapeutic properties, and the pharmaceutical compositions containing the same.
N-(Sulfo-lower alkyl)amides of (3-trifluoromethylphenoxy)-(4-chlorophenyl)acetic acid which are useful in the treatment of atherosclerosis. The N-(sulfo-lower alkyl)amides of (3-trifluoromethylphenoxy) (4-chlorophenyl)-acetic acid are prepared by reacting a (3-trifluoromethylphenoxy) (4-chlorophenyl)acetyl halide with an amino-lower alkanesulfonic acid.
A method of providing an ameliorating effect on the subjective symptoms and objective signs of a patient with heart failure comprising administering to said patient an effective amount of taurine.
Derivatives of benzoylphenoxyalkanoic acids corresponding to the formula: ##STR1## wherein: X represents for example a halogen, R.sup.1 and R.sup.2 represent for example alkyl groups, R represents for example an aminoacid; and the salts thereof are new products showing antilipaemic and anticholesterolemic pharmacological activity.
